Supplemental testing for HCV: To what extent could nucleic acid amplification testing (NAT) replace HCV RIBA 3.0?

被引:0
|
作者
Valinsky, JE [1 ]
Bianco, C [1 ]
机构
[1] New York Blood Ctr, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:32S / 32S
页数:1
相关论文
共 50 条
  • [1] Results of HCV RIBA 2.0 indeterminate testing by using HCV RIBA 3.0
    Stramer, SL
    Brodsky, JP
    Peoples, B
    Porter, RA
    Wiack, M
    [J]. TRANSFUSION, 1999, 39 (10) : 107S - 107S
  • [2] Experience in nucleic acid amplification testing (NAT) for hepatitis C (HCV) in Canada
    Sher, GD
    Zuber, ED
    Scalia, V
    [J]. TRANSFUSION, 2000, 40 (10) : 89S - 89S
  • [3] Nucleic acid amplification testing (NAT) of midwestern blood donors for HCV RNA.
    Tegtmeier, GE
    Henderson, SE
    Blosser, JK
    [J]. TRANSFUSION, 1999, 39 (10) : 93S - 93S
  • [4] Nucleic acid amplification testing (NAT) for HIV and HCV among Chinese blood donors
    Ren, F
    Wang, J
    Lu, S
    Yao, F
    Zhu, F
    Bai, X
    Zheng, Y
    Gong, X
    Liu, C
    Yu, L
    Shan, H
    [J]. TRANSFUSION, 2005, 45 (03) : 91A - 91A
  • [5] HCV nucleic acid amplification testing (NAT): Window period case studies.
    Strauss, D
    Kessler, D
    delValle, C
    Jayakar, H
    Katz, Y
    Rios, M
    Valinsky, JE
    [J]. TRANSFUSION, 2002, 42 (09) : 80S - 80S
  • [6] Summary of nucleic acid testing (NAT) for HIV and HCV RNA
    Katz, Y
    Jayakar, H
    Strauss, D
    Valinsky, JE
    [J]. TRANSFUSION, 2005, 45 (03) : 92A - 92A
  • [7] Results of nucleic acid amplification testing (NAT) for HIV and HCV RNA: 1999-2001.
    Strauss, D
    Kessler, D
    Katz, Y
    Jayakar, H
    Anderson, G
    Valinsky, JE
    [J]. TRANSFUSION, 2002, 42 (09) : 79S - 80S
  • [8] The financial impact of the first variance to eliminate RIBA supplemental testing for HCV-NAT positive donors
    Pratt, ML
    Thomas, KJ
    [J]. TRANSFUSION, 2005, 45 (03) : 184A - 184A
  • [9] Early detection of HIV and HCV infections in donors by nucleic acid testing (NAT)
    Geier, SS
    Barfield, KD
    Bauer, MJ
    [J]. HUMAN IMMUNOLOGY, 2005, 66 : S16 - S16
  • [10] Dynamics of HCV viremia during early HCV infection: Implications for minipool (MP) vs individual donation (ID) nucleic acid amplification testing (NAT)
    Busch, MP
    Giachetti, C
    Conrad, A
    Gallarda, J
    Mimms, LT
    Peddada, L
    Charles, H
    Raia, S
    Fiebig, EW
    Wright, D
    [J]. TRANSFUSION, 2000, 40 (10) : 25S - 26S